文献速递外周动脉疾病

经皮股腘动脉旁路术:DETOUR系统的2年结果

Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System.
PubMed 文献 · J Endovasc Ther · 2021-08-31

2年随访显示MAE率22.0%,靶肢体症状性深静脉血栓2.8%,无肺栓塞报告,Kaplan-Meier分析的一期、辅助一期和二期通畅率分别为79±5%、79±5%和86±4%。结论认为该系统是股腘动脉开放旁路术安全有效的经皮替代方案,对长段、严重钙化或闭塞病变提供持久选择。

要点

  • DETOUR系统经静脉途径置入覆膜支架,2年一期通畅率79±5%,二期通畅率86±4%。
  • MAE率22.0%,靶肢体深静脉血栓2.8%,无肺栓塞报告。
  • 适用于长段(平均371±51 mm)、严重钙化(67%)或闭塞(96%)股腘动脉病变。

核心结论

  • DETOUR系统作为经皮股腘动脉旁路替代方案,2年内安全有效且结果良好。
  • 该系统为长段、严重钙化或闭塞的股腘动脉病变提供持久的替代传统腔内和开放手术的选择。

研究设计与样本

  • DETOUR系统经静脉途径置入Torus覆膜支架。
  • 纳入病变长度>10 cm,平均371±55 mm。

主要发现

  • 慢性完全闭塞和严重钙化分别占病变的96%和67%。
  • 核心实验室评估总病变长度平均371±51 mm,平均闭塞长度159±88 mm。
  • 技术和手术成功率均为96%,79/82肢体内满意释放装置且无院内MAE。
  • MAE率22.0%,包括3例无关死亡(4%)、12例CD-TVR(16%)和1例大截肢(1%)。
  • 靶肢体深静脉血栓发生率2.8%,无肺栓塞报告。

临床怎么用

  • 对于长段、严重钙化或闭塞的股腘动脉病变,DETOUR系统可作为开放旁路术的经皮替代方案。
  • 需关注靶肢体深静脉血栓风险,术后监测深静脉血栓。

局限性

  • 单臂研究设计,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigated the 2-year safety and effectiveness of the PQ Bypass DETOUR system as a percutaneous femoropopliteal bypass. MATERIALS AND METHODS: Seventy-eight patients with 82 long-segment femoropopliteal lesions were enrolled in this prospective, single-arm, multicenter study. The DETOUR system deployed Torus stent grafts directed through a transvenous route. Eligible patients included those with lesions of >10 cm and average of 371±55 mm. Key safety endpoints included major adverse events (MAEs) and symptomatic deep venous thrombosis in the target limb. Effectiveness endpoints included primary patency defined as freedom from ≥50% stenosis, occlusion, or clinically-driven target vessel revascularization (CD-TVR), primary assisted, and secondary patency. RESULTS: Chronic total occlusions and severe calcium occurred in 96% and 67% of lesions, respectively. Core laboratory-assessed total lesion length averaged 371±51 mm with a mean occlusion length of 159±88 mm. The rates of technical and procedural success were 96%, with satisfactory delivery and deployment of the device without in-hospital MAEs in 79/82 limbs. The MAE rate was 22.0%, with 3 unrelated deaths (4%), 12 CD-TVRs (16%), and 1 major amputation (1%). Deep venous thrombosis developed in 2.8% of target limbs, and there were no reported pulmonary emboli. Primary, assisted primary, and secondary patency rates by the Kaplan-Meier analysis were 79±5%, 79±5%, and 86±4%, respectively. CONCLUSIONS: The PQ Bypass DETOUR system is a safe and effective percutaneous alternative to femoropopliteal open bypass with favorable results through 2 years. The DETOUR system provides a durable alternative to conventional endovascular modalities and open surgery for patients with long, severely calcified, or occluded femoropopliteal lesions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Halena G, Krievins DK, Scheinert D, et al. Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System. J Endovasc Ther. 2021. PMID: 34465223. doi:10.1177/15266028211034862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。